Clinical Evidence that Moderate Exercise Reduces the Risk of Cancer Returning
Study Shows GLP-1 Agonists Significantly Reduced Cancer Risk
FDA approves Belzutifan, the first oral therapy for advanced, rare tumors.
New FDA approvals are changing cancer treatment.
